课题基金 / 基金详情

Bipolar & Schizophrenia Consortium for Parsing Intermediate Phenotypes

Bipolar & Schizophrenia Consortium for Parsing Intermediate Phenotypes
双极性
批准号:
7389335
负责人:
Carol A Tamminga
金额:
$83.55万
依托单位国家:
美国
项目类别:
财政年份:
2007
资助国家:
美国
项目状态:
已结题
起止时间:
2007-09-29 至 2011-05-31
关键词:
AddressAdultAffectAffectiveAll SitesAlzheimer&aposs DiseaseAmygdaloid structureAnatomyAnimal ModelAppendixAreaAttentionBaltimoreBehavioralBiologicalBipolar DisorderBloodBlood specimenBrainBrain regionCandidate Disease GeneChicagoChronicClassClassificationClinicalClinical assessmentsCognitionCognitiveCollaborationsCollectionConflict (Psychology)ConsentConsultationsDataData AnalysesData CollectionDevelopmentDiagnosisDiagnosticDimensionsDiseaseEP300 geneEmotionalEpisodic memoryEvaluationExhibitsExtramural ActivitiesEyeEye MovementsFactor AnalysisFamilyFamily memberFirst Degree RelativeFunctional Magnetic Resonance ImagingFunctional disorderFundingFutureGenesGeneticGenetic VariationGenotypeGoalsGoldGray unit of radiation doseHeritabilityHeterogeneityHippocampus (Brain)Human Genome ProjectImageIndividualInterviewInvestigationKnowledgeLaboratoriesLaboratory FindingLaboratory ProceduresLaboratory StudyLateralLeadMagnetic Resonance ImagingMarylandMeasuresMedicineMental disordersMethodologyMethodsMissionModelingNational Institute of Mental HealthNeurobiologyNeurocognitionNeurocognitiveNeuronsNeurosciencesNormal RangeOperative Surgical ProceduresPathway interactionsPatientsPatternPharmaceutical PreparationsPharmacologyPhenotypePhysiologicalPhysiologyPilot ProjectsPotassium HydroxidePrefrontal CortexProblem SolvingProceduresProtocols documentationPsychiatryPsychotic DisordersPublic HealthPublicationsRangeRateRecording of previous eventsRecruitment ActivityRecurrenceRelative (related person)ReportingResearchResearch InfrastructureResearch PersonnelResearch TrainingResourcesRiskRisk EstimateRoleSamplingSampling StudiesSchizophreniaSchizotypal Personality DisorderShort-Term MemorySiteSmooth PursuitSpecific qualifier valueStructureSubgroupSuperior temporal gyrusSymptomsSyndromeSystemTNFRSF5 geneTechnical ExpertiseTechniquesTemporal LobeTestingThalamic structureThinkingTimeUnited States National Institutes of HealthValidationVentricularVideoconferencesVideoconferencingVisitWorkbaseclinical phenotypecohortcomparativeconceptdata acquisitiondata managementdaydesigndisorder riskendophenotypeexperiencefrontal lobefunctional disabilitygenetic linkage analysisgenetic variantgray matterhuman studyimprovedinsightinterestmembermillisecondneural circuitneuroimagingneurophysiologynovel strategiesoculomotorpredictive pursuitprobandprogramsresponseskillssymposiumtherapy developmenttraitvigilancewhite matter

项目摘要

项目成果

Carol A Tamminga的其他基金

相似基金

相关文献

中文摘要
翻译
描述(由申请人提供):最近的研究提供了大量证据表明,精神分裂症(SZ)和精神病性双相情感障碍(BP)可能有重叠的病因决定因素。确定疾病相关的遗传效应是SZ和BP研究的主要焦点,对这两种疾病的诊断和治疗具有巨大的意义。努力是多方面的,最终目标是描述从特定遗传变异到神经元功能变化,改变大脑解剖结构,行为和功能障碍的因果路径。平行的努力已经确定并完善了几种稳定的、可遗传的、具有(部分)已知生物底物的替代性内表型,并且与精神病易感性相关。虽然许多这样的内源性表型已单独研究SZ,并在较小程度上在BP,没有研究全面评估了广泛的面板,这些标志物在这两种疾病的平行招聘,以及在何种程度上,他们标志着独立方面的精神病风险,或其重叠的两种疾病。这一系列的研究将可能影响我们对精神障碍的概念化,帮助我们在确定精神病的病理生理学方面取得关键性进展,并指导针对特定缺陷的新的特异性治疗方法的开发。拟议研究的总体目标是在精神分裂症和双相情感障碍患者及其未受影响的亲属中检查一组广泛的推定内表型,以便:1)表征SZ和精神病性BP之间的家族表型重叠程度; 2)识别两种疾病特有的内表型模式; 3)对比两种疾病内表型的遗传性。为了实现这些目标,我们将从五个中心招募500名SZ和500名BP I(有精神病)先证者,这些先证者的~1700-2000名一级亲属,以及500名无关的非精神病对照。我们将获得神经生理学的测量结果(例如,眼跟踪、P50门控、PPI和P300),神经认知(例如,注意力/警惕性,情景记忆和工作记忆),和脑结构(例如,特定脑区域中的灰色和白色物质的体积)。我们将为将来的基因研究收集血液。我们将评估SZ和BP亲属中内表型的家族聚集程度。建立SZ和BP家族内的内表型特征的相似性和差异性将为未来的遗传学研究提供重要的见解,并澄清有关病理生理学的共同和不同方面的概念,疾病内潜在的有意义的异质性,以及成人精神病学中两种最常见的精神病性障碍的临床界限。这项研究将由5个经验丰富的研究小组进行,他们有着密切和富有成效的合作历史。 公共卫生相关性:这个多地点项目将确定内在表型(或责任标记),在精神分裂症和双相情感障碍中是共享的和不同的。这些研究的结果将为未来的遗传学研究提供重要的见解,并澄清有关病理生理学的共同和不同方面的概念,疾病内潜在的有意义的异质性,以及成人精神病学中两种最常见的精神病性障碍的临床界限。
英文摘要
DESCRIPTION (provided by applicant): Recent studies provide considerable evidence that schizophrenia (SZ) and psychotic bipolar disorder (BP) may share overlapping etiologic determinants. Identifying disease-related genetic effects is a major focus in SZ and BP research, with enormous implications for diagnosis and treatment for these two disorders. Efforts have been multifaceted, with the ultimate goal of describing causal paths from specific genetic variants, to changes in neuronal functioning, to altered brain anatomy, to behavioral and functional impairments. Parallel efforts have identified and refined several alternative endophenotypes that are stable, heritable, have (partly) known biological substrates, and are associated with psychosis liability. Although many such endophenotypes have been individually studied in SZ, and to a lesser extent in BP, no study has comprehensively assessed a broad panel of these markers in the two disorders with parallel recruitment, and the extent to which they mark independent aspects of psychosis risk, or their overlap in the two disorders. This line of investigation will potentially impact our conceptualization of psychotic disorders, help us make critical strides to identify the pathophysiology of psychosis, and guide development of new specific treatments targeting particular deficits. The overall goal of the proposed research is to examine a broad panel of putative endophenotypes in affected individuals with schizophrenia and bipolar and their unaffected relatives in order to: 1) characterize the degree of familial phenotypic overlap between SZ and psychotic BP; 2) identify patterns of endophenotypes unique to the two disorders, and 3) contrast the heritability of endophenotypes across the disorders. To achieve these goals, we will recruit 500 SZ and 500 BP I (with psychosis) probands, ~1700-2000 1st degree relatives of these probands, and 500 unrelated non-psychiatric controls from five centers. We will obtain measures of neurophysiology (e.g., eye tracking, P50 gating, PPI, and P300), neurocognition (e.g., attention/vigilance, episodic and working memory), and brain structure (e.g., volumes of gray and white matter in specified brain regions). We will collect blood for future genetic studies. We will assess the degree of familial aggregation of endophenotypes in SZ and BP relatives. Establishing similarities and differences in the endophenotypic signatures within SZ and BP families will provide important insights for future genetic studies, and clarify concepts about common and distinct aspects of pathophysiology, potentially meaningful heterogeneity within disorders, and the clinical boundaries of the two commonest psychotic disorders in adult psychiatry. This research will be conducted by 5 experienced research groups, with a long history of close and productive collaboration. Public Health Relevance: This multisite project will identify endophenotypes (or liability markers) that are shared and different in schizophrenia and bipolar disorder. Findings from these studies will provide important insights for future genetic studies, and clarify concepts about common and distinct aspects of pathophysiology, potentially meaningful heterogeneity within disorders, and the clinical boundaries of the two commonest psychotic disorders in adult psychiatry.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
1/5 - Biomarkers/Biotypes, Course of Early Psychosis and Specialty Services (BICEPS)
  • 批准号:
    10683302
  • 项目类别:
  • 资助金额:
    $28.7万
  • 财政年份:
    2022
  • 负责人:
    Carol A Tamminga
  • 依托单位:
Reverse Translation of Psychosis - associated Hippocampal Hyperactivity in the mouse
  • 批准号:
    10670252
  • 项目类别:
  • 资助金额:
    $41.0万
  • 财政年份:
    2021
  • 负责人:
    Carol A Tamminga
  • 依托单位:
Reverse Translation of Psychosis - associated Hippocampal Hyperactivity in the mouse
  • 批准号:
    10473803
  • 项目类别:
  • 资助金额:
    $41.0万
  • 财政年份:
    2021
  • 负责人:
    Carol A Tamminga
  • 依托单位:
1/5 - Selective Antipsychotic Response to Clozapine in B-SNIP Biotype-1 (Clozapine)
  • 批准号:
    10397393
  • 项目类别:
  • 资助金额:
    $36.9万
  • 财政年份:
    2021
  • 负责人:
    Carol A Tamminga
  • 依托单位:
海外基金